Director AETNA sells shares

AETNA is a prominent name in the health industry. They are considered to be the prime health insurers in United States of America. AETNA has always been open to learning and thus has transformed their organizational structure with the changes in the health industry. They have a business strategy to invest on new technologies and merchandises in the field of health care. AETNA has a motive of expanding their business and invests on innovative customer care relationships. This has resulted in a renowned name in the financial sector.

On May 27^th, 2014 the director of AETNA Franklin Barbara Hackman confirmed of selling 2.665 AETNA shares.  AETNA stock prices on an average were $77.26 per share which compounded to a total of $205,897.90. After making this major transaction, Hackman now owns 26,109 shares of AETNA. This transition was made public after filing with Securities & Exchange Commission.

AETNA shares were opened at a rate of $77.40. For a 52 week high and low comparison AETNA has been fluctuating between $57.72 and $77.68. The 50 and 200 day average of AETNA is $72.71 and $72.71 respectively. The price to earnings ratio recorded is 13.62 whereas the market cap has reached to $27.663 billion.

AETNA published its earnings data on April 24^th for the masses. AETNA claimed to have a per share earnings of $ 1.98 for the three months which was $0.43 more than the estimate of $1.55. Even AETNA’s revenue increased the expected digits where $13.97 billion were obtained rather than $13.69 billion. This has resulted in a 46.9% increase in a year-over-year bases. For FY14 it is expected that the earnings per share would reach to $6.51.

Many analysts have given their stance over AETNA’s stocks. Morgan Stanley gave an overweight rating to AETNA whereas Zack’s reiterated gave a neutral rating for the stocks. Moreover Barclays also increased the price target where AETNA’s stocks have switched from $80 to $87.  This has also resulted in an overweight rating on AETNA stocks by Barclays. The stocks of AETNA have been given a buy rating by 13 analysts whereas 4 have kept it on hold. On an average the company has got a buy rating with the price target being $78.24 on an average.

It will not be wrong to say that AETNA has become the biggest gainer in the industry. Their stock prices are experiencing a major boost resulting in potential gains for the investors. AETNA had to restructure its strategy where the company after experiencing a victory streak for their first trimestral results. They expect this to gain further push thus they are working on revamping their previous outlook.

Hence in a nutshell, AETNA has gained immense stability in terms of stocks and revenues making it a must have for all investors.